Bluejay Diagnostics, Inc. Finance Lease, Right-of-Use Asset, after Accumulated Amortization
Bluejay Diagnostics, Inc. (BJDX) had Finance Lease, Right-of-Use Asset, after Accumulated Amortization of $13.97 thousand as of 2024-03-31, per its 10-Q filed 2024-05-15.
Discontinued › Balance Sheet › Assets
us-gaap:FinanceLeaseRightOfUseAsset · last filed 2024-05-15
- 2024-03-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $13.97K.
- 2023-12-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $15.15K.
- 2023-09-30: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $21.07K.
- 2022-12-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $21.07K.
| Period end | Finance Lease, Right-of-Use Asset, after Accumulated Amortization |
|---|---|
| 2024-03-31 | $13.97K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $15.15K 10-Q · filed 2024-05-15 |
| 2023-09-30 | $21.07K 10-Q · filed 2023-11-09 |
| 2022-12-31 | $21.07K 10-Q · filed 2023-11-09 |
| 2022-09-30 | $19.94K 10-Q · filed 2022-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |